Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01406730
Other study ID # FAU-IMP-4463
Secondary ID
Status Completed
Phase Phase 3
First received July 18, 2011
Last updated August 11, 2012
Start date July 2011
Est. completion date July 2012

Study information

Verified date August 2012
Source University of Erlangen-Nürnberg Medical School
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics CommissionGermany: Federal Ministry of Education and Research
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine the effect of 16 weeks of running exercise on various parameters related to heart, vascular systems, blood, and muscle in untrained males 30-50 years old.

Further, the investigators assess which of the above mentioned parameters may explain the increase of running performance most accurate.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria:

- males

- untrained (< 2 endurance exercise sessions/week)

- 30-50 years old

Exclusion Criteria:

- pathological changes of the heart

- inflammable diseases

- medication/diseases affecting cardiovascular system and muscle

- very low physical capacity (< 100 Watt at ergometry)

- obesity (BMI > 30 kg/m2)

- more than 2 weeks of absence during the interventional period

- more than 2 exercise session beside the intervention

- contraindication related to MRI-assessment (i.e. claustrophobia, magnetizable intracorporal artefacts)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
exercise
16 week of periodized progressive running exercise 2-4 times/week

Locations

Country Name City State
Germany Departement of Radiology, University of Erlangen-Nurnberg Erlangen
Germany Institute of Medical Physics, University of Erlangen-Nurnberg Erlangen
Germany Institute of Physical Education and Sport Sciences Erlangen

Sponsors (4)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Medical School Institute of Physical Education and Sports Sciences, Klinikum Nürnberg, University of Erlangen-Nürnberg

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Scharf M, Brem MH, Wilhelm M, Schoepf UJ, Uder M, Lell MM. Atrial and ventricular functional and structural adaptations of the heart in elite triathletes assessed with cardiac MR imaging. Radiology. 2010 Oct;257(1):71-9. doi: 10.1148/radiol.10092377. Epub 2010 Aug 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary myocardial mass/stroke volume Atrial and ventricular volume and mass indexes were assessed by magnetic resonance imaging (MRI) 4 month No
Secondary maximal oxygen uptake maximal oxygen uptake during running 4 month No
Secondary Resting metabolic rate Adaptation of resting metabolic rate to running exercise 4 month No
Secondary muscle strength/power Isometric muscle strength of the leg extensors Leg power as assessed by counter movement jump 4 month No
Secondary myocardial volume Functional and morphologic parameters of the heart as assessed by echocardiography 4 month No
Secondary Intima media thickness Carotid intima media thickness by high-resolution ultrasound 4 month No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1